about
Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromersImpaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptorCircadian-related heteromerization of adrenergic and dopamine D₄ receptors modulates melatonin synthesis and release in the pineal glandTelomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartmentsTargeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaineAdenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway.CD1a and MHC class I follow a similar endocytic recycling pathway.Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus.Post-translational membrane insertion of tail-anchored transmembrane EF-hand Ca2+ sensor calneurons requires the TRC40/Asna1 protein chaperone.Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineKaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes.Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: σ1-D1-H3 receptor complexes as key targets for reducing cocaine's effects.Challenges in the development of heteromer-GPCR-based drugs.Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.NCS-1 associates with adenosine A(2A) receptors and modulates receptor function.Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB).The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors.L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies.Detection of receptor heteromers involving dopamine receptors by the sequential BRET-FRET technology.Nascent membrane and secretory proteins differ in FRET-detected folding far inside the ribosome and in their exposure to ribosomal proteins.Homodimerization of adenosine A₁ receptors in brain cortex explains the biphasic effects of caffeine.L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus.Cotranslational protein integration into the ER membrane is mediated by the binding of nascent chains to translocon proteins.Intracellular calcium levels determine differential modulation of allosteric interactions within G protein-coupled receptor heteromers.Modulation of GABA transport by adenosine A1R-A2AR heteromers, which are coupled to both Gs- and G(i/o)-proteinsSec61alpha and TRAM are sequentially adjacent to a nascent viral membrane protein during its ER integrationThe Arf GEF GBF1 is required for GGA recruitment to Golgi membranesDesign and development of stapled transmembrane peptides that disrupt the activity of G-protein-coupled receptor oligomersModulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease
P50
Q27325489-50DE3720-7AA3-40BF-BF41-EB2306620A2FQ28472108-A8F58D97-85AB-4876-A502-AACF47171157Q28480542-97D5CE7B-1C94-48BA-A205-1A9ADBB3D6A9Q33830798-27FABAA4-3D7D-4AC5-9038-53F2BB3CC471Q33833534-8F3D3810-20EC-4A05-855D-DDEBFD5D2819Q34070354-232C9817-4D2D-4D8B-8625-4342D4ACBEF9Q34186022-39BC498E-A005-429A-8B6F-6B29DBEA2312Q34276531-B24ED603-2D58-4C84-8A1F-4E441CF5DE8DQ34512293-31FCC9ED-AB0C-48E3-916D-DCF169625561Q34568648-987F450E-71A5-40AA-BA37-DE5B0D6D0A70Q34593316-9EEE4DAD-02CB-4DC9-8131-BEF0C2E79B0DQ35030514-945FD0C8-73E5-415F-B0F1-3342A4CD227CQ35378033-99D04826-246F-4A03-827C-4D22CD037DC2Q35547856-74775F4D-6664-49EE-8936-EF1F4983FA21Q36439695-77B961DB-734B-495D-B72D-7831270EBB57Q37131945-E1F258CF-890E-44FB-9663-D0F3A651A685Q37617361-D44D1BAB-B623-49B5-A5AD-F0A8EF4A09B3Q38105687-C0049273-3923-41F6-898F-A654F71CD0D9Q38889500-AFA6FA8F-93F7-4CEE-9F7C-61BE23CD5F01Q39359086-1801925B-85DA-4009-8CD8-7B1EB2308096Q41969318-973ECD88-8C84-4485-BCCD-2BF185D35AB0Q42507369-40D26EC8-349F-4AC8-9414-8A1ECA8C4ADEQ42678643-9D6BBEDC-2E9C-46AA-A077-1FCC2C70FCDFQ45228276-F4987682-1ABE-4CCE-9002-E0A1E71CD2D4Q46115163-7F1DBEC4-1BE6-4A24-BE8C-5E498DE5C3C1Q47987631-F0C968E9-D6B0-411C-854E-B60D7D1A94FBQ48113534-F74B4947-B129-47C2-A0BA-EBEB3812DD0CQ48873583-E1E6275F-E8E6-45CA-920E-9C4C51173076Q54517210-BE016A7A-65B0-4C19-92E3-78505998FE8BQ55069652-3130DBDD-9EC7-43BC-B5AC-5440EFBAC7F8Q56554348-63929088-4CE5-4454-8DC7-C231166AFB25Q79433658-247E8193-4899-49D9-AC98-2755FE147762Q80708884-E5C24F39-71C1-426B-9B9E-9F9663065203Q92992890-30997A20-9FA5-495A-8D81-5C1FB2E589C6Q96228741-9AE3C1E2-A3D7-4BF4-A54A-52112791AE43
P50
description
researcher, ORCID id # 0000-0002-2225-5181
@en
wetenschapper
@nl
name
Peter McCormick
@ast
Peter McCormick
@en
Peter McCormick
@es
Peter McCormick
@nl
type
label
Peter McCormick
@ast
Peter McCormick
@en
Peter McCormick
@es
Peter McCormick
@nl
prefLabel
Peter McCormick
@ast
Peter McCormick
@en
Peter McCormick
@es
Peter McCormick
@nl
P106
P1153
35748662900
P31
P496
0000-0002-2225-5181